Response of a cell-surface NADH oxidase to the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenylurea) (LY181984) modulated by redox

Biochimica et Biophysica Acta - Biomembranes

Volumn 1369, Issue 2, 1998, Pages 185-192

  Morré, D James ^a   Wu, Lian Ying ^b   M Morré, Dorothy ^b  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Antitumor drug; Diarylsulfonylurea; Glutathione; Growth; HeLa cell; NADH oxidase; Oxidant; Plasma membrane; Redox; Sulfonylurea

Indexed keywords

1 (4 CHLOROPHENYL) 3 (4 METHYLPHENYLSULFONYL)UREA; ANTINEOPLASTIC AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SULFONYLUREA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HELA CELL; HUMAN; MEMBRANE VESICLE; OXIDATION REDUCTION STATE; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIVISION; CELL MEMBRANE; DITHIOTHREITOL; ENZYME ACTIVATION; HELA CELLS; HUMANS; HYDROGEN PEROXIDE; MULTIENZYME COMPLEXES; NADH, NADPH OXIDOREDUCTASES; OXIDATION-REDUCTION; RATS; SULFONYLUREA COMPOUNDS;

EID: 0032473385     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2736(97)00202-2     Document Type: Article

References (18)

1. Morré D.J., Morré D.M., Stevenson J., MacKellar W., McClure D. Biochim. Biophys. Acta. 1244:1994;133-140.
2. Morré D.J., Wilkinson F.E., Lawrence J., Cho N., Paulik M. Biochim. Biophys. Acta. 1236:1995;237-243.
3. Morré D.J., Wu L.-Y., Morré D.M. Biochim. Biophys. Acta. 1236:1995;237-243.
4. Morré D.J. Biochim. Biophys. Acta. 1240:1995;201-208.
5. Morré D.J., Wilkinson F.E., Kim C., Cho N., Lawrence J.L., Morré D.M., McClure D. Biochim. Biophys. Acta. 1236:1996;237-243.
6. Morré D.J., Reust T.J. Bioenerg. Biomemb. 29:1997;283-291.
7. Morré D.J., Morré D.M. Biotechnology. 7:1989;946-958.
8. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano E.K., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Annal. Biochem. 100:1985;76-85.
9. Dai S., Morré D.J., Geilin C.C., Almond-Roesler B., Orfanos C.E., Morré D.M. Mol. Cell. Biochem. 166:1997;101-109.
10. Morré D.J., Chueh P.-J., Morré D.M. Proc. Natl. Acad. Sci. U.S.A. 92:1995;1831-1835.
11. Morré D.M., Morré D.J. Protoplasma. 184:1995;188-195.
12. Morré D.M., Dai S., Y. Wu L.-, Morré D.J. FASEB J. 10:1996;A525.
13. Wolvetang E.J., Larm J.A., Moutsoulas P., Lawen A. Cell Growth Differ. 7:1996;1315-1325.
14. Morré D.J., Merriman R., Tanzer L.R., Wu L.-Y., Morré D.M., MacKellar W.C. Protoplasma. 184:1995;203-208.
15. Gilbert H.F. J. Biol. Chem. 254:1982;12086-12091.
16. Levy D.I., Sucher N.J., Lipton S.A. Neurosci. Lett. 110:1990;291-296.
17. Majewska M.D., Bell J.A., London E.O. Brain Res. 537:1990;328-332.
18. Morré D.J., Geilin C., Wu L.-Y., deCabo R., Krasagakis K., Orfanos C.E., Morré D.M. Eur. J. Cancer. 32A:1996;1995-2003.